Detection of human cytomegalovirus-specific T lymphocytes in human blood: comparison of two methods
Tài liệu tham khảo
Aubert, 2001, Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants, J Infect Dis, 184, 55, 10.1086/323354
Einsele, 1995, PCR monitoring after BMT to reduce the incidence of CMV disease and the duration and side effects of antiviral therapy, Blood, 86, 2815, 10.1182/blood.V86.7.2815.2815
Ljungman, 1992, Treatment of interstitial pneumonitis due to cytomegalovirus with ganciclovir and intravenous immune globulin: experience of European Bone Marrow Transplant Group, Clin Infect Dis, 14, 831, 10.1093/clinids/14.4.831
Boeckh, 1999, Successful modification of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic bone marrow transplant recipients, Blood, 93, 1781, 10.1182/blood.V93.5.1781
Andrei, 2008, Novel inhibitors of human CMV, Curr Opin Investig Drugs, 9, 132
Boeckh, 2003, Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity, Blood, 101, 407, 10.1182/blood-2002-03-0993
Tomonari, 2004, Ganciclovir-related neutropenia after preemptive therapy for cytomegalovirus infection: comparison between cord blood and bone marrow transplantation, Ann Hematol, 83, 573, 10.1007/s00277-004-0887-2
Salzberger, 1997, Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome, Blood, 90, 2502, 10.1182/blood.V90.6.2502
Altman, 1996, Phenotypic analysis of antigen-specific T lymphocytes, Science, 274, 94, 10.1126/science.274.5284.94
Kern, 2002, Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals, J Infect Dis, 185, 1709, 10.1086/340637
Campbell, 2003, Detection and enrichment of antigen-specific CD4+ and CD8+ T cells based on cytokine secretion, Methods, 31, 150, 10.1016/S1046-2023(03)00125-7
Wlodkovic, 2008, Syto probes in the cytometry of tumor cell death, Cytometry, 73A, 496, 10.1002/cyto.a.20535
Wlodkovic, 2008, Multi parameter detection of apoptosis using red-excitable SYTO probes, Cytometry, 73A, 563, 10.1002/cyto.a.20564
Bland, 1999, Measuring agreement in method comparison studies, Stat Methods Med Res, 8, 135, 10.1191/096228099673819272
Altman DG, Machin D, Trevor N, Gardner MJ. Statistics with Confidence. Second Edition. BMJ Books 2001.
Middeldorp, 1984, Conditions for the detection of IgM and IgG antibodies against cytomegalovirus early and late antigens by ELISA, J Clin Microbiol, 20, 763, 10.1128/JCM.20.4.763-771.1984
Lacey, 2003, Relative dominance of HLA-B*07 restricted CD8+ T-lymphocyte immune responses to human cytomegalovirus pp65 in persons sharing HLA-A*02 HLA-B*07 alleles, Hum Immunol, 64, 440, 10.1016/S0198-8859(03)00028-4
Diamond, 1997, Development of a candidate HLA-A*0201 restricted peptide-based vaccine against human cytomegalovirus infection, Blood, 90, 1751, 10.1182/blood.V90.5.1751
Mc Laughlin-Taylor, 1994, Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus specific cytotoxic T lymphocytes, J Med Virol, 43, 103, 10.1002/jmv.1890430119
Mashishi, 2002, The ELISPOT assay: an easily transferable method for measuring cellular responses and identifying T cell epitopes, Clin Chem Lab Med, 40, 903, 10.1515/CCLM.2002.159
Özdemir, 2002, Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells, Immunobiology, 100, 3690
Cwynarski, 2001, Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation, Blood, 97, 1232, 10.1182/blood.V97.5.1232
Gratama, 2001, Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection, Blood, 98, 1358, 10.1182/blood.V98.5.1358